Selected Drugs Clear All
MultiCheck Results
- 5
Interactions
Avoid/Use Alternative |
||
|
Welireg
(belzutifan) + Yasmin
(drospirenone/ ethinyl estradiol) |
||
Avoid/Use Alternativebelzutifan + drospirenone (contraceptive) use additional non-hormonal or alternative contraception during and x28 days after belzutifan tx: combo may decr. drospirenone levels, contraceptive efficacy (hepatic metabolism induced) belzutifan + ethinyl estradiol (contraceptive) use additional non-hormonal or alternative contraception during and x28 days after belzutifan tx: combo may decr. ethinyl estradiol levels, contraceptive efficacy (hepatic metabolism induced) |
||
Monitor/Modify Tx |
||
|
Alahist CF
(dexbrompheniramine/ dextromethorphan/ phenylephrine) + Yasmin
(drospirenone/ ethinyl estradiol) |
||
Monitor/Modify Txphenylephrine + ethinyl estradiol (contraceptive) monitor BP: combo may incr. risk of HTN (additive effects) |
||
|
Pomalyst
(pomalidomide) + Yasmin
(drospirenone/ ethinyl estradiol) |
||
Monitor/Modify Txpomalidomide + drospirenone (contraceptive) monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects) pomalidomide + ethinyl estradiol (contraceptive) monitor CBC, thrombosis s/sx: combo may incr. pomalidomide levels, risk of serious infection, myelosuppression, other adverse effects; may incr. risk of thromboembolism (hepatic metabolism inhibited; additive effects) |
||
Additional Considerations |
||
|
Lacticaseibacillus rhamnosus
in Culturelle
|
||
|
separate administration from antibiotics by at least 2h; combo may alter Lacticaseibacillus rhamnosus probiotic efficacy |
||
|
phenylephrine
in Alahist CF
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||
|
dextromethorphan
in Alahist CF
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||